Passivating the Omicron SARS-CoV-2 variant with self-assembled nano peptides: Specificity, stability, and no cytotoxicity
The SARS-CoV-2 Omicron variant is called a "variant of concern" (VOC) which has spread all over the world at a faster rate than even the first SARS-CoV-2 outbreak despite travel restrictions. In order to combat the health consequences from a SARS-CoV-2 Omicron variant infection, the object...
Saved in:
Main Authors: | Alaa F. Nahhas (Author), Thomas J. Webster (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A review of treating viral outbreaks with self-assembled nanomaterial-like peptides: From Ebola to the Marburg virus
by: Alaa F. Nahhas, et al.
Published: (2022) -
Omicron variant in the current SARS-CoV-2 pandemic
by: Kaveh Nasiri, et al.
Published: (2022) -
Importation of SARS-CoV-2 Omicron variant in Beijing, China
by: Fu Li, et al.
Published: (2022) -
Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant
by: Nirmitee Mulgaonkar, et al.
Published: (2023) -
A comparison of severity of illness between the SARS-CoV-2 Omicron variant and Delta variant
by: Laura Peyton Ellis, et al.
Published: (2023)